• LAST PRICE
    1.2000
  • TODAY'S CHANGE (%)
    Trending Up0.0400 (3.4483%)
  • Bid / Lots
    1.1700/ 5
  • Ask / Lots
    1.2000/ 3
  • Open / Previous Close
    1.1800 / 1.1600
  • Day Range
    Low 1.1200
    High 1.2000
  • 52 Week Range
    Low 1.0509
    High 3.5500
  • Volume
    26,328
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.16
TimeVolumeTRIB
09:32 ET22011.18
09:43 ET15121.1699
10:03 ET9921.16
10:39 ET11301.1648
11:31 ET1001.12
11:56 ET1001.15
12:36 ET5201.16
12:45 ET3701.16
12:54 ET5001.1588
01:01 ET3001.16
01:19 ET1301.1625
01:24 ET9781.16
01:28 ET10201.1606
01:30 ET2001.162
02:06 ET10001.171
02:11 ET5001.1722
02:26 ET5001.16
02:29 ET2001.18
02:42 ET4001.1711
02:54 ET1001.17
02:56 ET2001.17
03:07 ET9901.1799
03:09 ET2001.1646
03:27 ET5001.17
03:45 ET1001.17
03:50 ET25501.1791
03:52 ET2001.175
03:54 ET22761.1999
03:56 ET2001.199
03:59 ET26241.2
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTRIB
Trinity Biotech PLC
13.6M
-0.4x
---
United StatesUTRS
Minerva Surgical Inc
10.0
0.0x
---
United StatesRVP
Retractable Technologies Inc
22.5M
-1.2x
---
United StatesSONX
Sonendo Inc
3.6M
-0.1x
---
United StatesDFCO
Dalrada Financial Corp
12.1M
-0.5x
---
United StatesAPYX
Apyx Medical Corp
44.2M
-1.6x
---
As of 2024-10-05

Company Information

Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide.

Contact Information

Headquarters
Ida Business Park Bray, Co Wicklow, IrelandBRAY, Ireland 18
Phone
---
Fax
---

Executives

President, Chief Executive Officer, Executive Director
John Gillard
Founder, Executive Director
Ronan O'caoimh
Chief Financial Officer, Chief Accounting Officer
Louise Tallon
Chief Technology Officer
Gary Keating
Chief Information Officer
Eibhlin Kelly

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$13.6M
Revenue (TTM)
$58.7M
Shares Outstanding
2.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.21
EPS
$-2.74
Book Value
$-15.67
P/E Ratio
-0.4x
Price/Sales (TTM)
0.2
Price/Cash Flow (TTM)
---
Operating Margin
-26.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.